/CGN.CN
CGN.CN Stock - Cognetivity Neurosciences Ltd.
Healthcare|Medical - Healthcare Information ServicesCNQ
$0.01+0.00%
+$0.00 (+0.00%) • Jul 23
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.40
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CGN.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.01
RISK/REWARD1:NaN
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.42
52W High$0.04
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $45,366 | N/A | N/A | N/A | N/A |
| Gross Profit | $20,732 | $-24,530 | $-11,448 | $-9,292 | $-3,942 |
| Gross Margin | 45.7% | N/A | N/A | N/A | N/A |
| Operating Income | $-6,390,000 | $-13,057,000 | $-2,393,000 | $-2,605,000 | $-4,212,305 |
| Net Income | $-7,434,000 | $-13,127,000 | $-1,928,000 | $-2,645,000 | $-4,192,618 |
| Net Margin | -16386.7% | N/A | N/A | N/A | N/A |
| EPS | $-0.08 | $-0.18 | $-0.03 | $-0.06 | $-0.10 |
Company Overview
Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CGN.CNBeat Rate
0%
Last 9 quarters
Avg Surprise
-130.7%
EPS vs Estimate
Beats / Misses
0/6
3 met exactly
Latest EPS
$-0.03
Q4 2023
EPS Surprise History
Q1 22
No data
Q2 22
-100.0%
$-0.02vs$-0.01
Q3 22
-100.0%
$-0.02vs$-0.01
Q4 22
-126.2%
$-0.02vs$-0.01
Q1 23
No data
Q2 23
-100.0%
$-0.02vs$-0.01
Q3 23
0.0%
$-0.02vs$-0.02
Q4 23
-50.0%
$-0.03vs$-0.02
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Feb 26, 2025 | — | — | — | — |
Q4 2024 | Nov 15, 2024 | — | — | — | — |
Q3 2024 | Sep 27, 2024 | — | — | — | — |
Q2 2024 | Jun 27, 2024 | — | — | — | — |
Q1 2024 | Jan 2, 2024 | — | — | — | — |
Q4 2023 | Dec 30, 2023 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Q3 2023 | Sep 29, 2023 | $-0.02 | $-0.02 | 0.0% | = MET |
Q2 2023 | Jun 29, 2023 | $-0.01 | $-0.02 | -100.0% | ✗ MISS |
Q1 2023 | Jan 31, 2023 | — | $-0.03 | — | — |
Q4 2022 | Dec 16, 2022 | $-0.01 | $-0.02 | -126.2% | ✗ MISS |
Q3 2022 | Sep 29, 2022 | $-0.01 | $-0.02 | -100.0% | ✗ MISS |
Q2 2022 | Jun 29, 2022 | $-0.01 | $-0.02 | -100.0% | ✗ MISS |
Q1 2022 | Jan 31, 2022 | — | $-0.06 | — | — |
Q4 2021 | Dec 17, 2021 | $-0.01 | $-0.08 | -700.0% | ✗ MISS |
Q3 2021 | Sep 29, 2021 | $-0.01 | $-0.01 | 0.0% | = MET |
Q2 2021 | Jun 29, 2021 | $-0.01 | $-0.01 | 0.0% | = MET |
Q1 2021 | Jan 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 23, 2020 | — | $-0.00 | — | — |
Q3 2020 | Sep 28, 2020 | — | $-0.01 | — | — |
Q2 2020 | Jun 29, 2020 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CGN.CN
What is CGN.CN's current stock price?
Cognetivity Neurosciences Ltd. (CGN.CN) is currently trading at $0.01 per share. The stock has moved +0.00% today.
What is the analyst price target for CGN.CN?
No analyst price targets are currently available for this stock.
What sector is Cognetivity Neurosciences Ltd. in?
Cognetivity Neurosciences Ltd. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the CNQ exchange.
What is CGN.CN's market cap?
Cognetivity Neurosciences Ltd. has a market capitalization of $0.00 billion, making it a small-cap company.
Does CGN.CN pay dividends?
No, Cognetivity Neurosciences Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorGSL.CN
Green Scientific Labs Holdings Inc.
$0.06
Mkt Cap: $0.0B
J.CN
Lotus Ventures Inc.
$0.01
Mkt Cap: $0.0B
MEDV.NE
Medivolve Inc.
$0.03
Mkt Cap: $0.0B
NEWU.V
Newtopia Inc.
$0.01
Mkt Cap: $0.0B
NHP.V
Lumiera Health Inc.
$0.01
Mkt Cap: $0.0B
NLTA.V
Enlighta Inc.
$0.07
Mkt Cap: $0.0B
NU.V
NeutriSci International Inc.
$0.01
Mkt Cap: $0.0B
PSYB.V
PsyBio Therapeutics Corp.
$0.01
Mkt Cap: $0.0B
SLHG.V
Skylight Health Group Inc.
$0.02
Mkt Cap: $0.0B
TREE.NE
Trees Corporation
$0.01
Mkt Cap: $0.0B
Explore stocks similar to CGN.CN for comparison